# FDA Inspection 653960 - CMP Pharma Inc - March 17, 2010

Source: https://www.keypedia.com/records/fda_inspections/cmp-pharma-inc/59a8d60c-373f-4961-8d02-3b99bf7e3dfb
Source feed: FDA_Inspections

> FDA Inspection 653960 for CMP Pharma Inc on March 17, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 653960
- Company Name: CMP Pharma Inc
- Inspection Date: 2010-03-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1217480 - 2023-09-01](https://www.keypedia.com/records/fda_inspections/cmp-pharma-inc/a07e9aa3-1d61-4e98-b6fa-a1eb8203af73)
- [FDA Inspection 1196186 - 2023-01-25](https://www.keypedia.com/records/fda_inspections/cmp-pharma-inc/bc1cb6d0-502e-4466-a24f-c2112c3fafce)
- [FDA Inspection 1061287 - 2018-06-28](https://www.keypedia.com/records/fda_inspections/cmp-pharma-inc/c28b42e9-e1b0-4e66-b1d1-67dd8a541c23)
- [FDA Inspection 1023838 - 2017-05-25](https://www.keypedia.com/records/fda_inspections/cmp-pharma-inc/6a636d14-83e2-46a8-bfeb-26ede5f82493)
- [FDA Inspection 1001769 - 2016-12-21](https://www.keypedia.com/records/fda_inspections/cmp-pharma-inc/fcd3b5c1-29ac-4bda-9490-ae6c7393e9ad)

Company: https://www.keypedia.com/companies/cmp-pharma-inc/dfe75ec5-dd7b-4835-a28a-178b728ddb2c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c